Skip to content

Evaluating the Treatment in the MZEB Aachen

Evaluating the Treatment in the the Center for Disabled People in Aachen (MZEB Aachen) - a Registry on Patients With Severe Disabilities

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT04781452
Acronym
EvalMZEB
Enrollment
2000
Registered
2021-03-04
Start date
2019-07-01
Completion date
2029-07-01
Last updated
2024-06-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Disability Physical, Intellectual Disability

Brief summary

Evaluation of patient characteristics, involved physicians and therapists as well as therapies in a German University Center for the Treatment of patients with intellectual disabilities and severe multiple disability (MZEB Aachen)

Detailed description

In the MZEB Aachen, since 11/2018 patients with intellectual disabilities and/or severe multiple disabilities are diagnosed, treated and accompanied for many years in a multidisciplinary setting with physicians, nurses, physiotherapists, ergo therapists, speech therapists and Support by social workers. MZEBs are considered to have a pilot function in the health care system, cooperating with therapists and physicians in the surroundings. This concept is established as a new concept in Germany in order to optimise health care for patients with disabilities. Thus we want to investigate patient characteristics, diagnoses, involved physicians and therapists as well as proposed therapies and disease progress in this center.

Interventions

OTHERstandard treatment

there ist no Intervention but our standart Treatment in the center

Sponsors

RWTH Aachen University
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to 80 Years
Healthy volunteers
No

Inclusion criteria

* intellectual disability and/or severe multiple disability (disability degree GdB at least 70 and at least one noticeable sign * willing to participate

Exclusion criteria

* housed in an Institution and/or prison

Design outcomes

Primary

MeasureTime frameDescription
change in number of therapy sessionsbaseline and after one year treatmentchange in the number of therapy sessions per month
Change in diagnosesbaseline and after one year treatmentChange in percentage of definite diagnoses

Countries

Germany

Contacts

Primary ContactAndrea Maier, MD
mzeb@ukaachen.de0049 241 8089606
Backup ContactRobin Steiner
rsteiner@ukaachen.de0049 241 8089606

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026